(1)
Repurposing Drugs As uS12 Ribosomal Protein Inhibitors to Overcome UTI Resistance in MDR Pseudomonas Strains: In Silico and in Vitro Study. IJBB 2024, 61 (11), 672-687. https://doi.org/10.56042/ijbb.v61i11.8728.